Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_06-cv-05840/USCOURTS-cand-3_06-cv-05840-0/pdf.json

Nature of Suit Code: 350
Nature of Suit: Motor Vehicle Personal Injury
Cause of Action: 28:1332 Diversity-Motor Vehicle Product Liability

---

376367v1 JOINT REQUEST TO VACATE INITIAL STATUS CONFERENCE CASE NO. 4:06-CV-05840-WDB

DRINKER BIDDLE & REATH LLP

50 Fremont Street, 20th Floor 

San Francisco, CA 94105 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

CHARLES F. PREUSS (State Bar No. 45783) 

BRENDA N. BUONAIUTO (State Bar No. 173919) 

DRINKER BIDDLE & REATH LLP

50 Fremont Street, 20th Floor 

San Francisco, California 94105 

Telephone: (415) 591-7500 

Facsimile: (415) 591-7510 

Attorneys for Defendants 

ORTHO-MCNEIL PHARMACEUTICAL, INC., JOHNSON & 

JOHNSON, and JOHNSON & JOHNSON PHARMACEUTICAL 

RESEARCH & DEVELOPMENT, L.L.C. 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA (OAKLAND) 

JENNIFER BAILEY, 

 Plaintiff, 

 v. 

ORTHO-MCNEIL PHARMACEUTICAL, 

INC.; JOHNSON & JOHNSON; 

JOHNSON & JOHNSON 

PHARMACEUTICAL RESEARCH AND 

DEVELOPMENT, L.L.C.; and Does 1 

through 50, inclusive, 

 Defendants. 

Case No. 4:06-CV-05840-WDB 

JOINT REQUEST TO VACATE 

INITIAL STATUS CONFERENCE AND 

RELATED DEADLINES 

 On March 1, 2006, the Judicial Panel on Multidistrict Litigation (“JPML”) created 

MDL 1742, In re: Ortho Evra Products Liability Litigation, ruling that all federal actions 

involving allegations of injury or death from use of the prescription drug Ortho Evra® be 

centralized for pre-trial purposes in the United States District Court for the Northern 

District of Ohio, before the Honorable David A. Katz, Case Number 1:06-CV-40000-

DAK. To date, over 250 cases have been transferred to MDL 1742, and transfers of 

additional “tag-along” actions are pending. Defendants requested that this action be 

deemed a “tag-along” and transferred to MDL No. 1742. On November 7, 2006, the 

JPML issued Conditional Transfer Order 25 (“CTO-25”), transferring this action to the 

MDL. Plaintiff does not oppose and consents to that transfer. 

Case 4:06-cv-05840-WDB Document 8 Filed 11/22/2006 Page 1 of 2
 Case 3:06-cv-05840-SI Document 10 Filed 11/27/06 Page 1 of 2
 2 

JOINT REQUEST TO VACATE INITIAL STATUS CONFERENCE CASE NO. 4:06-CV-05840-WDB

DRINKER BIDDLE & REATH LLP

50 Fremont Street, 20th Floor 

San Francisco, CA 94105 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

 The parties therefore respectfully request that, pending CTO-25 becoming 

effective and to achieve the judicial economies that underlie 28 U.S.C. Section 1407 

(Multi-District Litigation Procedures), this Court vacate the initial Status Conference, set 

for December 21, 2006. For these same reasons, the parties further request that the Court 

relieve the parties of the obligations to submit ADR Certifications on November 30, 2006 

and Case Management Statements and Initial Disclosures on December 14, 2006. 

Dated: November 22, 2006 GILLIN, JACOBSON, ELLIS & LARSEN 

/s/ Kristin Lucey (as authorized) 

KRISTIN LUCEY 

Attorneys for Plaintiff 

JENNIFER BAILEY 

Dated: November 22, 2006 DRINKER BIDDLE & REATH LLP 

/s/ Brenda N. Buonaiuto 

BRENDA N. BUONAIUTO 

Attorneys for Defendants 

ORTHO-MCNEIL PHARMACEUTICAL, 

INC., JOHNSON & JOHNSON, and 

JOHNSON & JOHNSON 

PHARMACEUTICAL RESEARCH & 

DEVELOPMENT, L.L.C. 

Case 4:06-cv-05840-WDB Document 8 Filed 11/22/2006 Page 2 of 2
 Case 3:06-cv-05840-SI Document 10 Filed 11/27/06 Page 2 of 2